Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-01-19 Sale | 2024-01-19 6:25 pm | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 12,900 | $1.28 | $16,512 | 584,662 (Direct) | View |
2023-01-19 Sale | 2023-01-20 4:29 pm | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 14,030 | $1.5 | $21,045 | 363,472 (Direct) | View |
2022-01-19 Sale | 2022-01-20 7:07 pm | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 8,833 | $2.09 | $18,461 | 482,616 (Direct) | View |
2021-09-21 Sale | 2021-09-23 5:12 pm | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 2,800 | $6.41 | $17,948 | 316,449 (Direct) | View |
2021-06-21 Sale | 2021-06-23 5:42 pm | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 2,938 | $4.37 | $12,839 | 319,249 (Direct) | View |
2020-06-01 Sale | 2020-06-03 4:43 pm | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 14,992 | $1.88 | $28,185 | 220,827 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-01-18 Option Award | 2024-01-19 6:25 pm | N/A 2034-01-18 | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 200,000 | $0 | 584,662 (Direct) | View |
2023-09-18 Option Award | 2023-09-20 4:30 pm | N/A 2033-09-18 | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
2023-09-13 Exercise | 2023-09-13 6:55 pm | N/A 2023-11-24 | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 34,090 | $0 | 397,562 (Direct) | View |
2023-09-13 Exercise | 2023-09-13 6:55 pm | N/A N/A | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 34,090 | $0.4 | 397,562 (Direct) | View |
2023-01-04 Option Award | 2023-01-06 4:28 pm | N/A 2033-01-04 | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 187,500 | $0 | 187,500 (Direct) | View |
2022-12-20 Exercise | 2022-12-20 4:38 pm | N/A 2023-02-28 | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 23,636 | $0 | 377,502 (Direct) | View |
2022-12-20 Exercise | 2022-12-20 4:38 pm | N/A N/A | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 23,636 | $0.4 | 377,502 (Direct) | View |
2022-01-18 Option Award(A) | 2022-01-28 4:51 pm | N/A 2032-01-18 | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 185,000 | $0 | 501,449 (Direct) | View |
2022-01-18 Option Award | 2022-01-20 7:07 pm | N/A 2032-01-18 | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 175,000 | $0 | 482,616 (Direct) | View |
2021-01-18 Option Award | 2021-01-20 6:18 pm | N/A 2031-01-18 | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 292,000 | $0 | 517,827 (Direct) | View |
2020-01-08 Option Award | 2020-01-10 6:02 pm | N/A 2030-01-08 | Clearside Biomedical Inc. | CLSD | Deignan Charles A. Chief Financial Officer | 100,000 | $0 | 303,856 (Direct) | View |